Ampersand Capital Partners Named a Top Private Equity Firm of 2025 by GrowthCap

BOSTON, Aug. 21, 2025 /PRNewswire/ -- Ampersand Capital Partners ("Ampersand"), a growth equity firm with a nearly 40-year history of building leading companies in healthcare and life sciences, has been named a GrowthCap Top Private Equity Firm of 2025.

"We are proud to once again receive recognition from GrowthCap as a Top Private Equity Firm of 2025," said Herb Hooper, Managing Partner of Ampersand. "Ampersand's focused strategy in healthcare and life sciences has consistently enabled us to identify breakthrough opportunities and scale industry leaders. We are excited to continue partnering with exceptional founders and management teams to enable future innovations across the healthcare ecosystem."

GrowthCap continuously monitors private equity firms, their deal activity, and their people, while filtering out the noise to develop the most informed perspective possible. This year's selections highlight firms that have demonstrated a consistent ability to serve as exceptional partners to companies and their management teams as they scale and establish a more competitive market position. While financial performance is a consideration, GrowthCap's evaluation focuses more on a firm's fundamental capabilities in creating or enhancing company value in a repeatable and predictable manner.

To see the full list of honorees and learn more about the selection criteria and methodology, please visit the GrowthCap website.

Disclaimer: This award was provided by GrowthCap on August 19, 2025. Ampersand submitted a nomination to be considered for the GrowthCap Top Private Equity Firms 2025 list and, once selected by GrowthCap as an honoree, Ampersand paid a publishing and copyright fee to GrowthCap to promote this award. The data provided in this award publication is for informational purposes only and should not be construed as investment advice, endorsement, nor recommendation. GrowthCap believes the information in this publication to be accurate but does not verify its accuracy independently and does not warrant or guarantee that it is accurate or complete. GrowthCap has no obligation to provide any updates or changes to the information. No investment decisions should be made using this information.

About Ampersand Capital Partners

Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in the healthcare sector. With offices in Boston, MA, and Amsterdam, Netherlands, Ampersand leverages a unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm's core healthcare sectors. For additional information, visit www.ampersandcapital.com or follow us on LinkedIn.

SOURCE Ampersand Capital Partners